ERT demonstrates effectiveness in treating Fabry disease
By Whang, byung-woo | translator Hong, Ji Yeon
24.10.11 05:00:47
가나다라
0
Antonio Pisani, a professor in the Department of Nephrology at the University of Naples Federico II
Emphasizes monitoring when switching between medicines after using ERT for a first-line treatment of Fabry disease
New treatments under development for LSD…"Early diagnosis and early treatment are essential"
"'It has been 20 years since ERT treatments became available for patients with Fabry disease. More treatment options are available to treat Fabry disease, but selecting treatment options and strategy requires precise attention based on research data."
Analysis suggests that the treatment environment for rare diseases has improved due to the emergence of Enzyme Replacement Therapy (ERT) to treat lysosomal storage disease (LSD), such as Fabry disease.
New treatment strategies and research for treatments are being conducted to complement the limitations of ERTs. For example, studies on treatments like Substrate Reduction Therapy (SRT) are being conducted.
▲Antonio Pisani, a professor in the Department of Nephrology at the University of Naples Federico II.
However, cons
Whang, byung-woo(tuai@dailypharm.com)
If you want to see the full article, please JOIN US (click)